Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS
Proper management of multiple sclerosis treatment requires feedback from clinical practice, which is provided by registries. This article focuses on introducing the Czech national multiple sclerosis registry, ReMuS, and examines the availability and use of disease-modifying drugs ...